COO, CFO AND SECRETARY
Thu, Feb 15, 2024
Feb 15
exercised or converted securities in DAWN
1,375 shares @ $0.00
Decreased holdings by -12.50%
Net across this filing: +2.80% (+7,584 shares)
Option Exercise
Sale tied to a same-time option exercise
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology